Gain Therapeutics Inc (GANX)

[ProfitScout]

$GANX Gain Therapeutics: A True Revolution In Drug Development At Venture-Like Pricing

Aug. 19, 2021 12:29 PM ET Gain Therapeutics, Inc. (GANX)
https://seekingalpha.com/article/4450667-gain-therapeutics-revolution-in-drug-development-at-venture-like-pricing?utm_source=otcmarkets&utm_medium=referral

Summary
Gain’s cutting-edge precision medicine platform and novel compounds enable therapeutic access to previously undruggable targets.
Public investors can access this disruptive technology at a venture-like valuation.
A clean balance sheet funds the business until H2 2023, with multiple value inflections expected.
Management has a track record of creating value through pharma partnerships and exits.
Approaching top-line data for lead compound in GBA1 Parkinson’s has game-changing potential.